⌘K

Login Start Free

Home/Insiders/Brennan Peter F

BP

SEC Insider//CIK 0001501353

Brennan Peter F

CIK 00015013531 companyNEW YORK, NY

Transactions

13

Companies

1

Filings

5

CIK

0001501353

Recent Transactions

13 trades

Exercise/Conversion
CALMARE THERAPEUTICS Inc
Common Stock
2018-02-12+4,594,117→ 13,850,181 total
Conversion
CALMARE THERAPEUTICS Inc
Warrant
2018-02-12$0.60/sh+123,530→ 123,530 total
Conversion
CALMARE THERAPEUTICS Inc
Warrant
2018-02-12$0.60/sh+411,765→ 535,295 total
Conversion
CALMARE THERAPEUTICS Inc
Warrant
2018-02-12$0.13/sh+764,706→ 1,300,001 total
Conversion
CALMARE THERAPEUTICS Inc
Warrant
2018-02-12$0.13/sh+1,882,362→ 3,182,353 total
Conversion
CALMARE THERAPEUTICS Inc
Warrant
2018-02-12$0.13/sh+1,411,765→ 4,594,117 total
Award
CALMARE THERAPEUTICS Inc
Options
2015-01-02+10,000→ 2,419,981 total
Award
CALMARE THERAPEUTICS Inc
Common Stock
2015-01-02+2,500→ 1,368,615 total
Award
CALMARE THERAPEUTICS Inc
Common Stock
2014-01-31+2,500→ 1,360,386 total
Award
CALMARE THERAPEUTICS Inc
Options
2014-01-02+10,000→ 2,409,981 total
Award
CALMARE THERAPEUTICS Inc
Common Stock
2013-03-21+2,500→ 1,371,886 total
Other
CALMARE THERAPEUTICS Inc
Common Stock
2012-12-28$0.47/sh−121,960→ 1,369,386 total
Other
CALMARE THERAPEUTICS Inc
Common Stock
2012-12-28$0.47/sh+121,960→ 1,369,386 total

Companies

1

CALMARE THERAPEUTICS Inc
Director

Recent Filings

5

Address

237 PARK AVENUE SUITE 900

NEW YORK, NY, 10017

View on SEC.gov